Recent Publications

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Haifa Jabara, Yu Weng, Tatyana Sannikova, Raif Geha et al. “TRAF2 and TRAF3 independently mediate immunoglobulin class switching driven by CD40.” International Immunology 2009 21(4):477-488; doi:10.1093/intimm/dxp013

Haoli Jin, Lalit Kumar, Clinton Mathias, David Zurakowski, Hans Oettgen, Leonid Gorelik, and Raif Geha . “Toll-like receptor 2 is important for the Th1 response to cutaneous sensitization. “ J Allergy Clin Immunol 2009 123(4): 875-882; doi:10.1016/j.jaci.2009.02.007 Esra Ozcan, Lilit

Garibyan, John Lee, and Raif Geha. “TACI drives plasma cell differentiation in LPS activated B cells.” Journal of Allergy and Clinical Immunology 2009 123(2): Supp. 1, S94; doi:10.1016/j.jaci.2008.12.335

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
More optionsSearch
Condition & Treatments
Search for a Condition or Treatment:
View allSearch
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO